Ignite Creation Date:
2025-12-25 @ 4:59 AM
Ignite Modification Date:
2026-02-04 @ 4:14 AM
Study NCT ID:
NCT02248818
Status:
COMPLETED
Last Update Posted:
2017-04-07
First Post:
2014-09-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
AZD8108 SAD/MAD in Healthy Volunteers
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'ClinicalTrialTransparency@astrazeneca.com', 'title': 'Joel Posner MD', 'organization': 'AstraZeneca LP'}, 'certainAgreement': {'restrictionType': 'GT60', 'piSponsorEmployee': False, 'restrictiveAgreement': True}, 'limitationsAndCaveats': {'description': 'Conversion of AZD8108 to active moiety AZD6567 was rapid, concentrations of AZD8108 were almost all below the level of quantification, no PK parameters were calculable for AZD8108 concentrations.'}}, 'adverseEventsModule': {'timeFrame': 'SAD cohorts 2 weeks, MAD cohorts up to 1 month', 'description': 'From Day -1 (entry into unit) until 14 days after last dose (15 days for SAD cohorts and up to 29 days for MAD cohorts) note Mad Cohort 6, stopped due to randomisation error in pharmacy had 15 days of follow up for adverse events.', 'eventGroups': [{'id': 'EG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1', 'otherNumAtRisk': 6, 'otherNumAffected': 6, 'seriousNumAtRisk': 6, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2', 'otherNumAtRisk': 6, 'otherNumAffected': 4, 'seriousNumAtRisk': 6, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3', 'otherNumAtRisk': 6, 'otherNumAffected': 4, 'seriousNumAtRisk': 6, 'seriousNumAffected': 0}, {'id': 'EG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3', 'otherNumAtRisk': 6, 'otherNumAffected': 3, 'seriousNumAtRisk': 6, 'seriousNumAffected': 0}, {'id': 'EG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5', 'otherNumAtRisk': 6, 'otherNumAffected': 3, 'seriousNumAtRisk': 6, 'seriousNumAffected': 0}, {'id': 'EG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6', 'otherNumAtRisk': 8, 'otherNumAffected': 1, 'seriousNumAtRisk': 8, 'seriousNumAffected': 0}, {'id': 'EG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7', 'otherNumAtRisk': 6, 'otherNumAffected': 4, 'seriousNumAtRisk': 6, 'seriousNumAffected': 0}, {'id': 'EG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7', 'otherNumAtRisk': 4, 'otherNumAffected': 3, 'seriousNumAtRisk': 4, 'seriousNumAffected': 0}], 'otherEvents': [{'term': 'Leukopenia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Blood and lymphatic system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Palpitations', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Cardiac disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Nasopharyngitis', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Rash pustular', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Infections and infestations', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Muscle Twitching', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Musculoskeletal and connective tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Dysguesia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 6, 'numAffected': 6}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Nystagmus', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 2, 'numAffected': 2}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Euphoric mood', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 2, 'numAffected': 2}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Halucination, visual', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Irritability', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Nasal congestion', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Respiratory, thoracic and mediastinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Dyspepsia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Nausea', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Gastrointestinal disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Chest Pain', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'General disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Dizziness', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Headache', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Sensory disturbance', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Nervous system disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Dysphoria', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Initial insomnia', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 1, 'numAffected': 1}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Nightmare', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Psychiatric disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}, {'term': 'Dermatitis acneiform', 'stats': [{'groupId': 'EG000', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG001', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG002', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG003', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG004', 'numAtRisk': 6, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG005', 'numAtRisk': 8, 'numEvents': 0, 'numAffected': 0}, {'groupId': 'EG006', 'numAtRisk': 6, 'numEvents': 1, 'numAffected': 1}, {'groupId': 'EG007', 'numAtRisk': 4, 'numEvents': 0, 'numAffected': 0}], 'organSystem': 'Skin and subcutaneous tissue disorders', 'assessmentType': 'NON_SYSTEMATIC_ASSESSMENT', 'sourceVocabulary': 'MedDRA version 17.1'}], 'frequencyThreshold': '1'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Safety Laboratory - Thyroid Stimulating Hormone Above Upper Limit of Normal', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '6', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '8', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '2', 'groupId': 'OG000'}, {'value': '3', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '4', 'groupId': 'OG004'}, {'value': '3', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}]}], 'paramType': 'NUMBER', 'timeFrame': 'Day -1 to 7 days after last dose', 'description': 'Safety Laboratory - Thyroid Stimulating Hormone participants with laboratory value above the upper limit of normal', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED', 'populationDescription': 'Safety population'}, {'type': 'PRIMARY', 'title': 'Pharmacokinetic :Area Under the Concentration Curve (0 to Infinity), AZD6765 After Single/1st Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '8', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '726', 'spread': '22.4', 'groupId': 'OG000'}, {'value': '2651', 'spread': '17.1', 'groupId': 'OG001'}, {'value': '4533', 'spread': '11.3', 'groupId': 'OG002'}, {'value': '2160', 'spread': '37.8', 'groupId': 'OG004'}, {'value': '4318', 'spread': '13.2', 'groupId': 'OG005'}, {'value': '4597', 'spread': '21.8', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Pre-dose,5,15,30 min, 1,1.5,2,3,4,6,8,10,12,14,16,24,48,(72 SAD only) hr after day 1 dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to infinity), AZD6765 after single/first dose of AZD8108', 'unitOfMeasure': 'hours*ng/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (those dosed with AZD8108)'}, {'type': 'PRIMARY', 'title': 'Pharmacokinetic :Area Under the Concentration Curve (0 to 24 Hour), AZD6765 MAD Day 6 Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '2061', 'spread': '34.7', 'groupId': 'OG004'}, {'value': '4408', 'spread': '26.3', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24 hr after Day 6 dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to 24 hour), AZD6765 MAD Day 6 dose of AZD8108 Cohort 5 \\& 7, Cohort 6 did not reach Day 6', 'unitOfMeasure': 'hours*ng/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (those dosed with AZD8108)'}, {'type': 'PRIMARY', 'title': 'Pharmacokinetic :Area Under the Concentration Curve (0 to Infinity), AZD6765 MAD Day 12 Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '2837', 'spread': '47.6', 'groupId': 'OG004'}, {'value': '6733', 'spread': '30.2', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48, 72 hr after Day 12 dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to infinity), AZD6765 MAD Day 12 dose of AZD8108 Cohort 5 \\& 7, Cohort 6 did not reach Day 12', 'unitOfMeasure': 'hours*ng/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (those dosed with AZD8108)'}, {'type': 'PRIMARY', 'title': 'Pharmacokinetic :Area Under the Concentration Curve (0 to 24 Hours), AZD6765 After DAY 12 Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '2191', 'spread': '38.1', 'groupId': 'OG004'}, {'value': '4670', 'spread': '20.7', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16, and 24 hours after dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to 24 hours), AZD6765 after Day 12 dose of AZD8108 cohort 5 \\& 7, Cohort 6 dod not reach Day 12', 'unitOfMeasure': 'hours*ng/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (those dosed with AZD8108)'}, {'type': 'PRIMARY', 'title': 'Pharmacokinetic : Maximum Concentration of AZD6765 After Single/1st Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '8', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '50.1', 'spread': '22.4', 'groupId': 'OG000'}, {'value': '148', 'spread': '19.3', 'groupId': 'OG001'}, {'value': '264', 'spread': '17.8', 'groupId': 'OG002'}, {'value': '146', 'spread': '27.5', 'groupId': 'OG004'}, {'value': '287', 'spread': '22.7', 'groupId': 'OG005'}, {'value': '236', 'spread': '10.6', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,25,48,972 SAD only)hr after Day 1 dose', 'description': 'Pharmacokinetic : Maximum concentration of AZD6765 after single/first dose of AZD8108', 'unitOfMeasure': 'ng/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (those dosed with AZD8108)'}, {'type': 'PRIMARY', 'title': 'Pharmacokinetic : Maximum Concentration of AZD6765 After MAD Day 6 Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '176', 'spread': '23.9', 'groupId': 'OG004'}, {'value': '330', 'spread': '18.7', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Pre-dose, 5,15.30 min, 1,1.5,2,3,4,6,8,10,12,16,24 hr after Day 6 dose', 'description': 'Pharmacokinetic : Maximum concentration of AZD6765 after MAD Day 6 dose of AZD8108, Cohorts 5 \\& 7, Cohort 6 did not reach Day 6', 'unitOfMeasure': 'ng/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (those dosed with AZD8108) MAD cohorts 5 \\& 7'}, {'type': 'PRIMARY', 'title': 'Pharmacokinetic : Maximum Concentration of AZD6765 After MAD Day 12 Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '197', 'spread': '30.4', 'groupId': 'OG004'}, {'value': '337', 'spread': '11.3', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48,72 hr after Day 12 dose', 'description': 'Pharmacokinetic : Maximum concentration of AZD6765 after MAD Day 12 dose of AZD8108, Cohorts 5 \\& 7, Cohort 6 did not reach Day 12', 'unitOfMeasure': 'ng/mL', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (those dosed with AZD8108) MAD cohorts 5 \\& 7'}, {'type': 'SECONDARY', 'title': 'Pharmacokinetic: Time to Maximum Plasma Concentration of AZD6765 After Single (SAD)/ 1st (MAD) Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '8', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '1.75', 'groupId': 'OG000', 'lowerLimit': '1.00', 'upperLimit': '3.03'}, {'value': '2.00', 'groupId': 'OG001', 'lowerLimit': '1.00', 'upperLimit': '3.00'}, {'value': '2.50', 'groupId': 'OG002', 'lowerLimit': '1.00', 'upperLimit': '6.00'}, {'value': '1.25', 'groupId': 'OG004', 'lowerLimit': '1.00', 'upperLimit': '4.00'}, {'value': '1.28', 'groupId': 'OG005', 'lowerLimit': '1.00', 'upperLimit': '3.00'}, {'value': '2.55', 'groupId': 'OG006', 'lowerLimit': '1.52', 'upperLimit': '10.00'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48,(72 SAD only) hr after day 1 dose', 'description': 'Pharmacokinetic: Time to Maximum plasma concentration of AZD6765 after single (SAD) / first (MAD) dose AZD8108', 'unitOfMeasure': 'hours', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic population (subjects dosed with AZD8108)'}, {'type': 'SECONDARY', 'title': 'Pharmacokinetic: Fraction of Equivalent Dose of AZD6765 Excreted in Urine (SAD) After Single Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}, {'units': 'Participants with urine volume data', 'counts': [{'value': '5', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '5', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '0', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '0', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '48.8', 'spread': '55.2', 'groupId': 'OG000'}, {'value': '33.8', 'spread': '30.1', 'groupId': 'OG001'}, {'value': '38.8', 'spread': '8.24', 'groupId': 'OG002'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Collection 0-6, 6-12,12-24, 24-48, (48-72 SAD only) hy after Day 1 dose', 'description': 'Pharmacokinetic: Fraction of equivalent dose of AZD6765 excreted in urine (SAD) after single dose of AZD8108 (Cohorts 1 - 3)', 'unitOfMeasure': 'Percent', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'typeUnitsAnalyzed': 'Participants with urine volume data', 'denomUnitsSelected': 'Participants with urine volume data', 'populationDescription': 'Pharmacokinetic Population (Cohorts 1-3) AZD8108 dosed'}, {'type': 'SECONDARY', 'title': 'Pharmacokinetic: Fraction of Equivalent Dose of AZD6765 Excreted in Urine (MAD) After Day 12 Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '49.4', 'spread': '28.1', 'groupId': 'OG004'}, {'value': '30.2', 'spread': '35.5', 'groupId': 'OG006'}]}]}], 'paramType': 'GEOMETRIC_MEAN', 'timeFrame': 'Collection 0-6, 0-12, 12-24, 24-48, 48-72 hr after Day 12 dose', 'description': 'Pharmacokinetic: Fraction of equivalent dose of AZD6765 excreted in urine (MAD) after Day 12 dose of AZD8108 Cohorts 5 \\& 7, Cohort 6 did not reach day 12', 'unitOfMeasure': 'Percent', 'dispersionType': 'Geometric Coefficient of Variation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic Population (Cohorts 1-3) AZD8108 dosed'}, {'type': 'SECONDARY', 'title': 'Pharmacokinetic: Time to Maximum Plasma Concentration of AZD6765 After Day 12 (MAD) Dose of AZD8108', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'categories': [{'measurements': [{'value': '1.75', 'groupId': 'OG004', 'lowerLimit': '0.50', 'upperLimit': '2.00'}, {'value': '1.80', 'groupId': 'OG006', 'lowerLimit': '1.00', 'upperLimit': '3.00'}]}]}], 'paramType': 'MEDIAN', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48,72 hours after Day 12 dose', 'description': 'Pharmacokinetic: Time to Maximum plasma concentration of AZD6765 after Day 12 (MAD) dose AZD8108 Cohorts 5 \\& 7, Cohort 6 did not reach day 12', 'unitOfMeasure': 'hours', 'dispersionType': 'Full Range', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic population (subjects dosed with AZD8108)'}, {'type': 'SECONDARY', 'title': 'Pharmacokinetic: Accumulation Index for Area Under Concentration Curve (0 to 24 Hour) MAD', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '0', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'title': 'Day 6', 'categories': [{'measurements': [{'value': '1.30', 'spread': '0.181', 'groupId': 'OG004'}, {'value': '1.37', 'spread': '0.224', 'groupId': 'OG006'}]}]}, {'title': 'Day 12', 'categories': [{'measurements': [{'value': '1.39', 'spread': '0.254', 'groupId': 'OG004'}, {'value': '1.44', 'spread': '0.165', 'groupId': 'OG006'}]}]}], 'paramType': 'MEAN', 'timeFrame': 'Day 12 compared to Day 1', 'description': 'Pharmacokinetic: Accumulation index for Area Under Concentration Curve (0 to 24 hour) MAD Cohorts 5 \\& 7, cohort 6 did not reach day 12 \\[accumulation index (Day 6 or 12 /Day1)\\]', 'unitOfMeasure': 'ratio', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Pharmacokinetic population, MAD Cohorts 5 \\& 7'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'EEG Parameter (DAY 1) - Gamma - Change From Baseline in Total Area of the Brain (Eyes Closed)- Consistent Change in Either Direction', 'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'OG000'}, {'value': '6', 'groupId': 'OG001'}, {'value': '6', 'groupId': 'OG002'}, {'value': '6', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '8', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'title': '0.5 hours after dose', 'categories': [{'measurements': [{'value': '-0.069', 'spread': '0.3715', 'groupId': 'OG000'}, {'value': '-0.272', 'spread': '0.2422', 'groupId': 'OG001'}, {'value': '-0.166', 'spread': '0.1880', 'groupId': 'OG002'}, {'value': '.0141', 'spread': '0.2358', 'groupId': 'OG003'}, {'value': '-0.343', 'spread': '0.3348', 'groupId': 'OG004'}, {'value': '0.087', 'spread': '0.3979', 'groupId': 'OG005'}, {'value': '-0.154', 'spread': '0.2555', 'groupId': 'OG006'}, {'value': '0.128', 'spread': '0.5069', 'groupId': 'OG007'}]}]}, {'title': '1 hour after dose', 'categories': [{'measurements': [{'value': '0.101', 'spread': '0.2638', 'groupId': 'OG000'}, {'value': '-0.238', 'spread': '0.4504', 'groupId': 'OG001'}, {'value': '-0.140', 'spread': '0.2520', 'groupId': 'OG002'}, {'value': '-0.003', 'spread': '0.1467', 'groupId': 'OG003'}, {'value': '-0.109', 'spread': '0.5843', 'groupId': 'OG004'}, {'value': '0.092', 'spread': '0.3466', 'groupId': 'OG005'}, {'value': '-0.063', 'spread': '0.2291', 'groupId': 'OG006'}, {'value': '-0.121', 'spread': '0.2005', 'groupId': 'OG007'}]}]}, {'title': '1.5 hours after dose', 'categories': [{'measurements': [{'value': '-0.113', 'spread': '0.2616', 'groupId': 'OG000'}, {'value': '-0.161', 'spread': '0.6017', 'groupId': 'OG001'}, {'value': '-0.069', 'spread': '0.2095', 'groupId': 'OG002'}, {'value': '0.097', 'spread': '0.3402', 'groupId': 'OG003'}, {'value': '0.211', 'spread': '0.5514', 'groupId': 'OG004'}, {'value': '-0.052', 'spread': '0.3888', 'groupId': 'OG005'}, {'value': '0.016', 'spread': '0.3687', 'groupId': 'OG006'}, {'value': '0.313', 'spread': '0.2701', 'groupId': 'OG007'}]}]}, {'title': '2 hours after dose', 'categories': [{'measurements': [{'value': '0.244', 'spread': '0.2577', 'groupId': 'OG000'}, {'value': '-0.347', 'spread': '0.3231', 'groupId': 'OG001'}, {'value': '-0.080', 'spread': '0.2324', 'groupId': 'OG002'}, {'value': '-0.086', 'spread': '0.2350', 'groupId': 'OG003'}, {'value': '-0.303', 'spread': '0.4675', 'groupId': 'OG004'}, {'value': '-0.142', 'spread': '0.2639', 'groupId': 'OG005'}, {'value': '-0.097', 'spread': '0.2185', 'groupId': 'OG006'}, {'value': '0.019', 'spread': '0.2661', 'groupId': 'OG007'}]}]}, {'title': '3 hours after dose', 'categories': [{'measurements': [{'value': '0.214', 'spread': '0.2120', 'groupId': 'OG000'}, {'value': '-0.254', 'spread': '0.2461', 'groupId': 'OG001'}, {'value': '-0.108', 'spread': '0.1569', 'groupId': 'OG002'}, {'value': '0.126', 'spread': '0.1181', 'groupId': 'OG003'}, {'value': '-0.369', 'spread': '0.4360', 'groupId': 'OG004'}, {'value': '0.058', 'spread': '0.4186', 'groupId': 'OG005'}, {'value': '0.011', 'spread': '0.3292', 'groupId': 'OG006'}, {'value': '0.247', 'spread': '0.4936', 'groupId': 'OG007'}]}]}, {'title': '5 hours after dose', 'categories': [{'measurements': [{'value': '-0.225', 'spread': '0.1615', 'groupId': 'OG000'}, {'value': '-0.454', 'spread': '0.2641', 'groupId': 'OG001'}, {'value': '-0.014', 'spread': '0.1025', 'groupId': 'OG002'}, {'value': '0.138', 'spread': '0.3071', 'groupId': 'OG003'}, {'value': '-0.514', 'spread': '0.4117', 'groupId': 'OG004'}, {'value': '-0.073', 'spread': '0.3506', 'groupId': 'OG005'}, {'value': '-0.25', 'spread': '0.2971', 'groupId': 'OG006'}, {'value': '-0.151', 'spread': '0.2954', 'groupId': 'OG007'}]}]}, {'title': '8 hours after dose', 'categories': [{'measurements': [{'value': '0.222', 'spread': '0.5150', 'groupId': 'OG000'}, {'value': '-0.263', 'spread': '0.1219', 'groupId': 'OG001'}, {'value': '-0.086', 'spread': '0.3075', 'groupId': 'OG002'}, {'value': '0.091', 'spread': '0.4193', 'groupId': 'OG003'}, {'value': '-0.125', 'spread': '0.4958', 'groupId': 'OG004'}, {'value': '-0.169', 'spread': '0.3217', 'groupId': 'OG005'}, {'value': '-0.124', 'spread': '0.3209', 'groupId': 'OG006'}, {'value': '0.034', 'spread': '0.3623', 'groupId': 'OG007'}]}]}], 'paramType': 'MEAN', 'timeFrame': '8 hours after dose', 'description': 'EEG parameter (DAY 1) - Gamma - Change from baseline in Total Area of the Brain (eyes closed) - to identify a dose related change in EEG gamma bands to assess target engagement, a consistent change in either direction relative to placebo would be of interest', 'unitOfMeasure': 'uV2', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Safety population'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'EEG Parameter (DAY 6) - Gamma - Change From Baseline in Total Area of the Brain (Eyes Closed)- Consistent Change in Either Direction', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'title': 'Pre-dose Day 6 dose', 'categories': [{'measurements': [{'value': '-0.167', 'spread': '0.3959', 'groupId': 'OG004'}, {'value': '0.080', 'spread': '0.4827', 'groupId': 'OG006'}, {'value': '0.128', 'spread': '0.3311', 'groupId': 'OG007'}]}]}, {'title': '0.5 hours after dose', 'categories': [{'measurements': [{'value': '-0.514', 'spread': '0.3729', 'groupId': 'OG004'}, {'value': '0.131', 'spread': '0.3518', 'groupId': 'OG006'}, {'value': '0.384', 'spread': '0.7434', 'groupId': 'OG007'}]}]}, {'title': '1 hour after dose', 'categories': [{'measurements': [{'value': '-0.322', 'spread': '0.6343', 'groupId': 'OG004'}, {'value': '0.063', 'spread': '0.2129', 'groupId': 'OG006'}, {'value': '-0.123', 'spread': '0.3713', 'groupId': 'OG007'}]}]}, {'title': '1.5 hours after dose', 'categories': [{'measurements': [{'value': '-0.353', 'spread': '0.2722', 'groupId': 'OG004'}, {'value': '0.109', 'spread': '0.0729', 'groupId': 'OG006'}, {'value': '0.375', 'spread': '0.5060', 'groupId': 'OG007'}]}]}, {'title': '2 hours after dose', 'categories': [{'measurements': [{'value': '-0.460', 'spread': '0.2219', 'groupId': 'OG004'}, {'value': '0.279', 'spread': '0.5172', 'groupId': 'OG006'}, {'value': '0.223', 'spread': '0.3813', 'groupId': 'OG007'}]}]}, {'title': '3 hours after dose', 'categories': [{'measurements': [{'value': '-0.263', 'spread': '0.4014', 'groupId': 'OG004'}, {'value': '0.016', 'spread': '0.1550', 'groupId': 'OG006'}, {'value': '0.435', 'spread': '0.3796', 'groupId': 'OG007'}]}]}, {'title': '5 hours after dose', 'categories': [{'measurements': [{'value': '-0.350', 'spread': '0.7782', 'groupId': 'OG004'}, {'value': '0.031', 'spread': '0.2103', 'groupId': 'OG006'}, {'value': '-0.018', 'spread': '0.6197', 'groupId': 'OG007'}]}]}, {'title': '8 hours after dose', 'categories': [{'measurements': [{'value': '-0.454', 'spread': '0.4568', 'groupId': 'OG004'}, {'value': '-0.028', 'spread': '0.3062', 'groupId': 'OG006'}, {'value': '0.271', 'spread': '0.3849', 'groupId': 'OG007'}]}]}], 'paramType': 'MEAN', 'timeFrame': '8 hours after dose', 'description': 'EEG parameter (DAY 6) - Gamma - Change from baseline in Total Area of the Brain (eyes closed) Cohort 5 \\& 7, Cohort 6 did not reach Day 6; to identify a dose related change in EEG gamma bands to assess target engagement, a consistent change in either direction compared to placebo was of interest', 'unitOfMeasure': 'uV2', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Safety population'}, {'type': 'OTHER_PRE_SPECIFIED', 'title': 'EEG Parameter (DAY 12) - Gamma - Change From Baseline in Total Area of the Brain (Eyes Closed) - Consistent Change in Either Direction', 'denoms': [{'units': 'Participants', 'counts': [{'value': '0', 'groupId': 'OG000'}, {'value': '0', 'groupId': 'OG001'}, {'value': '0', 'groupId': 'OG002'}, {'value': '0', 'groupId': 'OG003'}, {'value': '6', 'groupId': 'OG004'}, {'value': '0', 'groupId': 'OG005'}, {'value': '6', 'groupId': 'OG006'}, {'value': '4', 'groupId': 'OG007'}]}], 'groups': [{'id': 'OG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'OG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'OG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'OG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'OG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'OG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'OG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'OG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}], 'classes': [{'title': 'Pre dose Day 12', 'categories': [{'measurements': [{'value': '-0.075', 'spread': '0.5040', 'groupId': 'OG004'}, {'value': '-0.065', 'spread': '0.1789', 'groupId': 'OG006'}, {'value': '0.015', 'spread': '0.1749', 'groupId': 'OG007'}]}]}, {'title': '0.5 hours post dose', 'categories': [{'measurements': [{'value': '-0.309', 'spread': '0.7025', 'groupId': 'OG004'}, {'value': '-0.134', 'spread': '0.2459', 'groupId': 'OG006'}, {'value': '0.334', 'spread': '0.3440', 'groupId': 'OG007'}]}]}, {'title': '1 hours post dose', 'categories': [{'measurements': [{'value': '0.193', 'spread': '1.4967', 'groupId': 'OG004'}, {'value': '-0.107', 'spread': '0.1970', 'groupId': 'OG006'}, {'value': '0.253', 'spread': '0.3448', 'groupId': 'OG007'}]}]}, {'title': '1.5 hours post dose', 'categories': [{'measurements': [{'value': '0.073', 'spread': '0.9299', 'groupId': 'OG004'}, {'value': '-0.062', 'spread': '0.1783', 'groupId': 'OG006'}, {'value': '0.373', 'spread': '0.3358', 'groupId': 'OG007'}]}]}, {'title': '2 hours post dose', 'categories': [{'measurements': [{'value': '-0.207', 'spread': '0.6381', 'groupId': 'OG004'}, {'value': '-0.087', 'spread': '0.3025', 'groupId': 'OG006'}, {'value': '-0.046', 'spread': '0.2830', 'groupId': 'OG007'}]}]}, {'title': '3 hours post dose', 'categories': [{'measurements': [{'value': '-0.119', 'spread': '0.6208', 'groupId': 'OG004'}, {'value': '-0.024', 'spread': '0.2590', 'groupId': 'OG006'}, {'value': '0.234', 'spread': '0.3109', 'groupId': 'OG007'}]}]}, {'title': '5 hours post dose', 'categories': [{'measurements': [{'value': '-0.506', 'spread': '0.4329', 'groupId': 'OG004'}, {'value': '0.040', 'spread': '0.1775', 'groupId': 'OG006'}, {'value': '0.090', 'spread': '0.4258', 'groupId': 'OG007'}]}]}, {'title': '8 hours post dose', 'categories': [{'measurements': [{'value': '0.022', 'spread': '1.0703', 'groupId': 'OG004'}, {'value': '-0.048', 'spread': '0.0975', 'groupId': 'OG006'}, {'value': '0.178', 'spread': '0.2510', 'groupId': 'OG007'}]}]}], 'paramType': 'MEAN', 'timeFrame': '8 hours after dose', 'description': 'EEG parameter (DAY 12) - Gamma - Change from baseline in Total Area of the Brain (eyes closed) Cohort 5 \\& 7 , Cohort 6 did not reach Day 12; to identify a dose related change in EEG gamma bands to assess target engagement, a consistent change in either direction compared to placebo would be of interest', 'unitOfMeasure': 'uV2', 'dispersionType': 'Standard Deviation', 'reportingStatus': 'POSTED', 'populationDescription': 'Safety population'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'AZD8108 20 mg SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'FG001', 'title': 'AZD8108 60 mg SAD', 'description': 'AZD8106 60 mg SAD, Cohort 2'}, {'id': 'FG002', 'title': 'AZD8108 95 mg SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'FG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'FG004', 'title': 'AZD8108 50 mg', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'FG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'FG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'FG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}, {'id': 'FG008', 'title': 'Screen', 'description': 'Screen - no treatment'}], 'periods': [{'title': 'Screening', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '155'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '48'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '107'}]}], 'dropWithdraws': [{'type': 'Protocol Violation', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '7'}]}, {'type': 'Study fully enrolled', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '14'}]}, {'type': 'Physician Decision', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '73'}]}, {'type': 'Withdrawal by Subject', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '6'}]}, {'type': 'Lost to Follow-up', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '7'}]}]}, {'title': 'Randomised Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '6'}, {'groupId': 'FG001', 'numSubjects': '6'}, {'groupId': 'FG002', 'numSubjects': '6'}, {'groupId': 'FG003', 'numSubjects': '6'}, {'groupId': 'FG004', 'numSubjects': '6'}, {'groupId': 'FG005', 'numSubjects': '8'}, {'groupId': 'FG006', 'numSubjects': '6'}, {'groupId': 'FG007', 'numSubjects': '4'}, {'groupId': 'FG008', 'numSubjects': '0'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '6'}, {'groupId': 'FG001', 'numSubjects': '6'}, {'groupId': 'FG002', 'numSubjects': '6'}, {'groupId': 'FG003', 'numSubjects': '6'}, {'groupId': 'FG004', 'numSubjects': '6'}, {'groupId': 'FG005', 'numSubjects': '0'}, {'groupId': 'FG006', 'numSubjects': '6'}, {'groupId': 'FG007', 'numSubjects': '4'}, {'groupId': 'FG008', 'numSubjects': '0'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '8'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}]}], 'dropWithdraws': [{'type': 'Administrative - randomization error', 'reasons': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}, {'groupId': 'FG003', 'numSubjects': '0'}, {'groupId': 'FG004', 'numSubjects': '0'}, {'groupId': 'FG005', 'numSubjects': '8'}, {'groupId': 'FG006', 'numSubjects': '0'}, {'groupId': 'FG007', 'numSubjects': '0'}, {'groupId': 'FG008', 'numSubjects': '0'}]}]}], 'recruitmentDetails': 'Healthy Adult volunteer study, Part 1: SAD: single ascending dose cohorts, followed by Part 2: MAD: multiple ascending dose cohorts. Plan was for each cohort to have 8 subjects, 2 placebo dosed and 6 AZD8108 dosed.', 'preAssignmentDetails': 'Protocol allowed for 258 subjects to be screened, only 155 subjects were screened before all cohorts for the study were filled and recruitment ended.'}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '6', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}, {'value': '6', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '8', 'groupId': 'BG005'}, {'value': '6', 'groupId': 'BG006'}, {'value': '4', 'groupId': 'BG007'}, {'value': '48', 'groupId': 'BG008'}]}], 'groups': [{'id': 'BG000', 'title': 'AZD8108 20 mg - SAD', 'description': 'AZD8108 20 mg SAD, Cohort 1'}, {'id': 'BG001', 'title': 'AZD8108 60 mg - SAD', 'description': 'AZD8108 60 mg SAD, Cohort 2'}, {'id': 'BG002', 'title': 'AZD8108 95 mg - SAD', 'description': 'AZD8108 95 mg SAD, Cohort 3'}, {'id': 'BG003', 'title': 'Placebo SAD', 'description': 'Placebo SAD, pooled across Cohorts 1 - 3'}, {'id': 'BG004', 'title': 'AZD8108 50 mg MAD', 'description': 'AZD8108 50 mg MAD, Cohort 5'}, {'id': 'BG005', 'title': 'AZD8108 90 mg MAD (6)', 'description': 'AZD8108 90 mg MAD, Cohort 6'}, {'id': 'BG006', 'title': 'AZD8108 90 mg MAD (7)', 'description': 'AZD8108 90 mg MAD, Cohort 7'}, {'id': 'BG007', 'title': 'Placebo MAD', 'description': 'Placebo MAD, pooled across Cohorts 5 \\& 7'}, {'id': 'BG008', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Continuous', 'classes': [{'categories': [{'measurements': [{'value': '36.0', 'spread': '10.81', 'groupId': 'BG000'}, {'value': '36.3', 'spread': '12.55', 'groupId': 'BG001'}, {'value': '38.7', 'spread': '10.53', 'groupId': 'BG002'}, {'value': '38.0', 'spread': '10.53', 'groupId': 'BG003'}, {'value': '36.7', 'spread': '7.89', 'groupId': 'BG004'}, {'value': '35.4', 'spread': '10.31', 'groupId': 'BG005'}, {'value': '31.2', 'spread': '2.64', 'groupId': 'BG006'}, {'value': '39.3', 'spread': '9.22', 'groupId': 'BG007'}, {'value': '36.0', 'spread': '9.62', 'groupId': 'BG008'}]}]}], 'paramType': 'MEAN', 'unitOfMeasure': 'Years', 'dispersionType': 'STANDARD_DEVIATION'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '3', 'groupId': 'BG008'}]}, {'title': 'Male', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '6', 'groupId': 'BG002'}, {'value': '5', 'groupId': 'BG003'}, {'value': '6', 'groupId': 'BG004'}, {'value': '8', 'groupId': 'BG005'}, {'value': '6', 'groupId': 'BG006'}, {'value': '4', 'groupId': 'BG007'}, {'value': '45', 'groupId': 'BG008'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Ethnicity (NIH/OMB)', 'classes': [{'categories': [{'title': 'Hispanic or Latino', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '5', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '13', 'groupId': 'BG008'}]}, {'title': 'Not Hispanic or Latino', 'measurements': [{'value': '4', 'groupId': 'BG000'}, {'value': '6', 'groupId': 'BG001'}, {'value': '5', 'groupId': 'BG002'}, {'value': '4', 'groupId': 'BG003'}, {'value': '4', 'groupId': 'BG004'}, {'value': '3', 'groupId': 'BG005'}, {'value': '5', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '33', 'groupId': 'BG008'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '1', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '2', 'groupId': 'BG008'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race (NIH/OMB)', 'classes': [{'categories': [{'title': 'American Indian or Alaska Native', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}]}, {'title': 'Asian', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '1', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '2', 'groupId': 'BG008'}]}, {'title': 'Native Hawaiian or Other Pacific Islander', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}]}, {'title': 'Black or African American', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '4', 'groupId': 'BG001'}, {'value': '3', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '2', 'groupId': 'BG005'}, {'value': '3', 'groupId': 'BG006'}, {'value': '2', 'groupId': 'BG007'}, {'value': '21', 'groupId': 'BG008'}]}, {'title': 'White', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '2', 'groupId': 'BG001'}, {'value': '2', 'groupId': 'BG002'}, {'value': '1', 'groupId': 'BG003'}, {'value': '1', 'groupId': 'BG004'}, {'value': '3', 'groupId': 'BG005'}, {'value': '3', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '15', 'groupId': 'BG008'}]}, {'title': 'More than one race', 'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '2', 'groupId': 'BG003'}, {'value': '2', 'groupId': 'BG004'}, {'value': '2', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '1', 'groupId': 'BG007'}, {'value': '10', 'groupId': 'BG008'}]}, {'title': 'Unknown or Not Reported', 'measurements': [{'value': '0', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '0', 'groupId': 'BG002'}, {'value': '0', 'groupId': 'BG003'}, {'value': '0', 'groupId': 'BG004'}, {'value': '0', 'groupId': 'BG005'}, {'value': '0', 'groupId': 'BG006'}, {'value': '0', 'groupId': 'BG007'}, {'value': '0', 'groupId': 'BG008'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE1'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}, 'primaryPurpose': 'BASIC_SCIENCE', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 258}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2014-11'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2017-03', 'completionDateStruct': {'date': '2015-09', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2017-03-09', 'studyFirstSubmitDate': '2014-09-23', 'resultsFirstSubmitDate': '2016-08-17', 'studyFirstSubmitQcDate': '2014-09-24', 'lastUpdatePostDateStruct': {'date': '2017-04-07', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2016-12-05', 'studyFirstPostDateStruct': {'date': '2014-09-25', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2017-01-27', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2015-09', 'type': 'ACTUAL'}}, 'outcomesModule': {'otherOutcomes': [{'measure': 'EEG Parameter (DAY 1) - Gamma - Change From Baseline in Total Area of the Brain (Eyes Closed)- Consistent Change in Either Direction', 'timeFrame': '8 hours after dose', 'description': 'EEG parameter (DAY 1) - Gamma - Change from baseline in Total Area of the Brain (eyes closed) - to identify a dose related change in EEG gamma bands to assess target engagement, a consistent change in either direction relative to placebo would be of interest'}, {'measure': 'EEG Parameter (DAY 6) - Gamma - Change From Baseline in Total Area of the Brain (Eyes Closed)- Consistent Change in Either Direction', 'timeFrame': '8 hours after dose', 'description': 'EEG parameter (DAY 6) - Gamma - Change from baseline in Total Area of the Brain (eyes closed) Cohort 5 \\& 7, Cohort 6 did not reach Day 6; to identify a dose related change in EEG gamma bands to assess target engagement, a consistent change in either direction compared to placebo was of interest'}, {'measure': 'EEG Parameter (DAY 12) - Gamma - Change From Baseline in Total Area of the Brain (Eyes Closed) - Consistent Change in Either Direction', 'timeFrame': '8 hours after dose', 'description': 'EEG parameter (DAY 12) - Gamma - Change from baseline in Total Area of the Brain (eyes closed) Cohort 5 \\& 7 , Cohort 6 did not reach Day 12; to identify a dose related change in EEG gamma bands to assess target engagement, a consistent change in either direction compared to placebo would be of interest'}], 'primaryOutcomes': [{'measure': 'Safety Laboratory - Thyroid Stimulating Hormone Above Upper Limit of Normal', 'timeFrame': 'Day -1 to 7 days after last dose', 'description': 'Safety Laboratory - Thyroid Stimulating Hormone participants with laboratory value above the upper limit of normal'}, {'measure': 'Pharmacokinetic :Area Under the Concentration Curve (0 to Infinity), AZD6765 After Single/1st Dose of AZD8108', 'timeFrame': 'Pre-dose,5,15,30 min, 1,1.5,2,3,4,6,8,10,12,14,16,24,48,(72 SAD only) hr after day 1 dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to infinity), AZD6765 after single/first dose of AZD8108'}, {'measure': 'Pharmacokinetic :Area Under the Concentration Curve (0 to 24 Hour), AZD6765 MAD Day 6 Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24 hr after Day 6 dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to 24 hour), AZD6765 MAD Day 6 dose of AZD8108 Cohort 5 \\& 7, Cohort 6 did not reach Day 6'}, {'measure': 'Pharmacokinetic :Area Under the Concentration Curve (0 to Infinity), AZD6765 MAD Day 12 Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48, 72 hr after Day 12 dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to infinity), AZD6765 MAD Day 12 dose of AZD8108 Cohort 5 \\& 7, Cohort 6 did not reach Day 12'}, {'measure': 'Pharmacokinetic :Area Under the Concentration Curve (0 to 24 Hours), AZD6765 After DAY 12 Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16, and 24 hours after dose', 'description': 'Pharmacokinetic : Area under the concentration curve (0 to 24 hours), AZD6765 after Day 12 dose of AZD8108 cohort 5 \\& 7, Cohort 6 dod not reach Day 12'}, {'measure': 'Pharmacokinetic : Maximum Concentration of AZD6765 After Single/1st Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,25,48,972 SAD only)hr after Day 1 dose', 'description': 'Pharmacokinetic : Maximum concentration of AZD6765 after single/first dose of AZD8108'}, {'measure': 'Pharmacokinetic : Maximum Concentration of AZD6765 After MAD Day 6 Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15.30 min, 1,1.5,2,3,4,6,8,10,12,16,24 hr after Day 6 dose', 'description': 'Pharmacokinetic : Maximum concentration of AZD6765 after MAD Day 6 dose of AZD8108, Cohorts 5 \\& 7, Cohort 6 did not reach Day 6'}, {'measure': 'Pharmacokinetic : Maximum Concentration of AZD6765 After MAD Day 12 Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48,72 hr after Day 12 dose', 'description': 'Pharmacokinetic : Maximum concentration of AZD6765 after MAD Day 12 dose of AZD8108, Cohorts 5 \\& 7, Cohort 6 did not reach Day 12'}], 'secondaryOutcomes': [{'measure': 'Pharmacokinetic: Time to Maximum Plasma Concentration of AZD6765 After Single (SAD)/ 1st (MAD) Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48,(72 SAD only) hr after day 1 dose', 'description': 'Pharmacokinetic: Time to Maximum plasma concentration of AZD6765 after single (SAD) / first (MAD) dose AZD8108'}, {'measure': 'Pharmacokinetic: Fraction of Equivalent Dose of AZD6765 Excreted in Urine (SAD) After Single Dose of AZD8108', 'timeFrame': 'Collection 0-6, 6-12,12-24, 24-48, (48-72 SAD only) hy after Day 1 dose', 'description': 'Pharmacokinetic: Fraction of equivalent dose of AZD6765 excreted in urine (SAD) after single dose of AZD8108 (Cohorts 1 - 3)'}, {'measure': 'Pharmacokinetic: Fraction of Equivalent Dose of AZD6765 Excreted in Urine (MAD) After Day 12 Dose of AZD8108', 'timeFrame': 'Collection 0-6, 0-12, 12-24, 24-48, 48-72 hr after Day 12 dose', 'description': 'Pharmacokinetic: Fraction of equivalent dose of AZD6765 excreted in urine (MAD) after Day 12 dose of AZD8108 Cohorts 5 \\& 7, Cohort 6 did not reach day 12'}, {'measure': 'Pharmacokinetic: Time to Maximum Plasma Concentration of AZD6765 After Day 12 (MAD) Dose of AZD8108', 'timeFrame': 'Pre-dose, 5,15,30 min, 1,1.5,2,3,4,6,8,10,12,16,24,48,72 hours after Day 12 dose', 'description': 'Pharmacokinetic: Time to Maximum plasma concentration of AZD6765 after Day 12 (MAD) dose AZD8108 Cohorts 5 \\& 7, Cohort 6 did not reach day 12'}, {'measure': 'Pharmacokinetic: Accumulation Index for Area Under Concentration Curve (0 to 24 Hour) MAD', 'timeFrame': 'Day 12 compared to Day 1', 'description': 'Pharmacokinetic: Accumulation index for Area Under Concentration Curve (0 to 24 hour) MAD Cohorts 5 \\& 7, cohort 6 did not reach day 12 \\[accumulation index (Day 6 or 12 /Day1)\\]'}]}, 'oversightModule': {'oversightHasDmc': True}, 'conditionsModule': {'conditions': ['Healthy Volunteers']}, 'descriptionModule': {'briefSummary': 'This is a randomized, double-blind, placebo-controlled study of single and multiple ascending dosage levels of AZD8108 in healthy volunteers. The study includes an up to 28-day screening period, an in-house period during which AZD8108 or placebo will be administered orally as a solution, and a 4- to 10-day follow-up period after discharge.', 'detailedDescription': 'In Part 1 of the study (single ascending dose portion), approximately 32 subjects will be randomly assigned. Eight (8) subjects will be randomized in each of 4 dosage-level cohorts (AZD8108 or placebo). Within each cohort, 6 subjects will be randomized to receive AZD8108 and 2 subjects will be randomized to receive placebo. Each subject will receive only one dose of either AZD8108 or placebo on Day 1. In Part 2 of the study (multiple ascending dose portion), approximately 24 subjects will be randomly assigned. Eight (8) subjects will be randomized in each of 3 dosage-level cohorts. Within each cohort, 6 subjects will be randomized to receive AZD8108 and 2 subjects will be randomized to receive placebo. Each subject will receive twelve doses of either AZD8108 or placebo'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '55 Years', 'minimumAge': '18 Years', 'healthyVolunteers': True, 'eligibilityCriteria': 'Inclusion Criteria: Inclusion Criteria: 1. Subjects must understand the nature of the study and must provide signed and dated written informed consent in accordance with local regulations before the conduct of any study-specific procedures. 2. Men and postmenopausal or surgically sterile women age 18-55 years inclusive. 3. Subjects must have a body mass index (BMI) between 19 and 30, inclusive and weigh between 50kg and 100kg inclusive. 4.Subjects must be fluent in English.\n\n\\-\n\nExclusion Criteria:1. A history or presence of a clinically significant hepatic, renal, gastrointestinal, cardiovascular, endocrine, respiratory, immunologic, hematologic, dermatologic, or neurologic abnormality. 2. A clinically significant abnormality on physical examination, neurological examination, EEG, ECG, vital signs or laboratory evaluations at screen or between screen and dose administration. 3. A history of seizure. 4.A history of head trauma, including closed head injury with loss of consciousness. 5.Any history of suicide attempt or suicidal behavior, or, in the opinion of the investigator, clinically significant risk of suicide or violent behavior. 6. Urine drug screen positive for a drug of abuse 7. A family history of schizophrenia, schizoaffective disorder, or psychosis in first degree relatives.'}, 'identificationModule': {'nctId': 'NCT02248818', 'acronym': 'AZD8108', 'briefTitle': 'AZD8108 SAD/MAD in Healthy Volunteers', 'organization': {'class': 'INDUSTRY', 'fullName': 'AstraZeneca'}, 'officialTitle': 'A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Ascending Doses of AZD8108 in Healthy Volunteers', 'orgStudyIdInfo': {'id': 'D5800C00001'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'AZD8108', 'description': 'Subjects will participate in 1 of 7 groups and receive single or multiple doses of AZD8108 or matching placebo. In each group 6 subjects will receive AZD8108', 'interventionNames': ['Drug: AZD8108']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo to match AZD8108', 'description': 'Subjects will participate in 1 of 7 groups and receive single or multiple doses of AZD8108 or matching placebo. In each group 2 subjects will receive matching placebo', 'interventionNames': ['Drug: Placebo']}], 'interventions': [{'name': 'AZD8108', 'type': 'DRUG', 'description': 'Drug: AZD8108 Single or Multiple doses administered orally as a solution.', 'armGroupLabels': ['AZD8108']}, {'name': 'Placebo', 'type': 'DRUG', 'description': 'Placebo to match AZD8108 Single or Multiple doses of matching placebo administered orally as a solution', 'armGroupLabels': ['Placebo to match AZD8108']}]}, 'contactsLocationsModule': {'locations': [{'zip': '10019', 'city': 'New York', 'state': 'New York', 'country': 'United States', 'facility': 'Clinilabs, Inc.', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}], 'overallOfficials': [{'name': 'Mina Pastagia, MD, MS', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Clinilabs, Inc.'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'AstraZeneca', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}